Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Breux

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
AIDS (London, England)|October 29, 1998
Opportunistic infections occurring during highly active antiretroviral treatmentC Michelet, C Arvieux, C François, et al.
Antiviral Therapy|July 19, 2005
Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patientsV Reliquet, V Ferré, C Hascoet, et al.
Antiviral Therapy|January 6, 2001
The VIRGO study: nevirapine, didanosine and stavudine combination therapy in antiretroviral-naive HIV-1-infected adultsF Raffi, V Reliquet, V Ferré, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
AIDS (London, England)|October 29, 1998
Opportunistic infections occurring during highly active antiretroviral treatmentC Michelet, C Arvieux, C François, et al.
Antiviral Therapy|July 19, 2005
Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patientsV Reliquet, V Ferré, C Hascoet, et al.
Antiviral Therapy|January 6, 2001
The VIRGO study: nevirapine, didanosine and stavudine combination therapy in antiretroviral-naive HIV-1-infected adultsF Raffi, V Reliquet, V Ferré, et al.
Pageof 4